N6 heterocyclic 8-modified adenosine derivatives
US6294522A · kind A · utility
72Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1999 |
| Grant date | Sep 25, 2001 |
| Priority date | — |
| Expiry date | Dec 3, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N.sup.6 heterocyclic 8 modified adenosine derivatives that are selective, partial or full adenosine A.sub.1 receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.